Things are looking up for the CBD sector. A report from a data company named Brightfield Group said that the industry may reach $1 billion worth of product sales by 2020 because of a compound annual growth rate (CAGR) of 55 percent in the next five years.
Online shops account for 64.5 percent of the sales, while 17.8 percent goes to smoke shops and nine percent to dispensaries. Health stores and offices of doctors also contribute to product sales.
The buzz behind the CBD industry
In both hemp and marijuana, there are chemical compounds called cannabinoids. They are significant to the plants as they give out its effects on the human body. There are at least 85 cannabinoids in the cannabis plant, and all of them have varying effects.
Out of the 85 cannabinoids, eight are considered as major acids, and these include cannabigerolic acid, cannabichromenenic acid, cannabigerovarinic acid, tetrahydrocannabivarinic acid, cannabidivarinic acid and cannabichromevarinic acid.
Cannabinoids are essential because they communicate with the receptors needed to keep body functions like sleeping patterns, appetite, movement and mood as normal as possible, and these receptors are found in the immune system and the central nervous system.
The most well-known are cannabidiol (CBD) and tetrahydrocannabinol (THC). Both of them have their respective benefits. However, the former is safer because CBD is not psychoactive, and hemp contains higher amounts of CBD than marijuana.
CBD’s benefits will attract the attention of consumers since it deals with alleviating their pain and calming them without receiving the euphoric effect that a person can get from THC, making it the safer choice between the two and adding another commodity in the market.
Leading the way
A report published in 2017 projected that the worldwide CBD oil market between 2017 and 2021 will grow at a 39.19 percent CAGR, with people’s interest in the medical benefits of hemp-derived CBD oil, especially in its capability of treating numerous diseases, driving the growth in the market. True enough, CBD-focused company PotNetwork Holding, Inc. (OTCMKTS:POTN) recorded 2017 as its most successful year yet, after a decade of being in the business.
PotNetwork managed to conceive new ways to share the perks of CBD to the public, and it quickly rose as one of the leading companies in the developing CBD industry.
Its Diamond CBD subsidiary produces and sells a wide collection of CBD-infused products such as oils, vape additives, creams, dabs, snacks and even hemp liquid for pets. It also distributes the Easy Grinder™, which is an herb grinder.
The company’s revenues continually exceeded its monthly targets. It managed to keep the momentum going in the last quarter of the year as its November revenues eclipsed October’s more than $1.6 million, which is also higher than the overall revenue of 2016.
PotNetwork also introduced new product lines named “LT Pain Master” and “Chong’s Choice CBD,” and teamed up with NFL legend Lawrence Taylor and actor-comedian Tommy Chong to respectively launch these new products.
Its Chill Gummies, which are gummies infused with CBD, also became the most popular product of PotNetwork when the company announced that it has distributed more than one million of the said product.
A bright future
Going into 2018, it looks like PotNetwork will continue its growth, with Diamond CBD seen as the primary driver behind it. On the first week of the year, the company’s shares skyrocketed by up to 375 percent, starting the New Year with a huge bang.
It is well-positioned to dominate the CBD oil market, which corresponds to a big portion of the overall cannabis market. New Frontier Data’s report estimated that in the years heading into 2025, it will continue to grow, and California’s legal cannabis sales are estimated to arrive at $2.8 billion in 2017 and $6.6 billion eight years later with a 12 percent CAGR.
The company also released its outlook on 2017, which stated that its acquisition of First Capital Venture Co. and Diamond CBD led to the strong infrastructure that it currently has. PotNetwork has not revealed the final data yet, but with its original revenue forecast set to go beyond $8.4 million, its numbers indicate that it was “50 percent greater than anticipated.”
With such a remarkable performance in 2017 and at the start of 2018, PotNetwork is at the forefront of the multi-billion dollar cannabis industry.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
Taur, a high-tech electric scooter that was funded via Kickstarter
Taur, a new electric scooter that was funded through a crowdfunding campaign on Kickstarter can now be purchased for $1.106...
V recovery versus K recovery: what is it going to be?
The markets continue to trace out what could prove to be an important top. There are no sell signals yet,...
Gold & Dow Jones’ step sum symmetry
Like the Dow Jones, gold too is range bound between its BEV Zero and BEV -10% lines below. This is...
Alibaba’s fintech branch goes public after receiving the permission
Ant received this Wednesday, October 21st the permission from the China Securities Regulatory Commission. The jump to the stock market...
Roche signs its new diabetes business manager in Spain to Isdin
The company Roche Diabetes Care Spain, part of the Swiss pharmaceutical group, has appointed Josep Maria Vallmajó to hold the...
Africa7 days ago
Why countries in southern Africa could become leaders in the cannabis sector
Featured6 days ago
B2B only: Spotcap sells credit business to Ferratum
Business7 days ago
Hot junior miner Rockridge Resources goes all-in at the Raney Gold Project
Business7 days ago
How to market your business during and after the pandemic